Effect of a monensin controlled-release capsule on rumen and blood metabolites in Florida Holstein transition cows.
The objective of this study was to determine the effect of a monensin controlled-release capsule administered intraruminally at dry-off on rumen volatile fatty acids, NH3, lactate, pH, and energy blood metabolites in transition dairy cows fed Florida typical diets. In March 2003, 24 cows (10 primiparous and 14 multiparous) dried-off 50 to 70 d before expected parturition were randomly assigned to a treatment (n=12, oral capsule of monensin) or a control group (n=12, no capsule). Both groups received the same diet and were exposed to the same environment and management conditions. At assignment, at 21 d before expected parturition, at calving, and at 7, 14, and 21 d postpartum, blood samples were taken and body condition scores were determined. At 10 d postpartum, rumen and blood samples were obtained in the morning before the first feeding and at 2, 4, and 6 h after feeding. Serum nonesterified fatty acids (NEFA), beta-hydroxybutyrate (BHBA), and glucose were measured. Rumen samples were analyzed for concentrations of acetic, propionic, butyric, L- and D-lactic acids, and NH3. Data for rumen and blood metabolites were analyzed by ANOVA, mixed models for repeated measures. Volatile fatty acids were not different between groups. Multiparous treated cows had a significant reduction in rumen NH3 at 6 h after feeding. Treatment with monensin significantly increased body condition score at calving in multiparous cows. During the postpartum period, NEFA and BHBA were noticeably lower in treated than in control primiparous cows. This difference was not observed in multiparous cows.
Melendez
P
P
College of Veterinary Medicine, University of Florida, Gainesville, 32610, USA.
Goff
J P
JP
Risco
C A
CA
Archbald
L F
LF
Littell
R
R
Donovan
G A
GA
D020155:3-Hydroxybutyric Acid / Q000097:blood; D000641:Ammonia / Q000032:analysis; D000704:Analysis of Variance; D000821:Animal Feed; D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002214:Capsules; D002417:Cattle / Q000097:blood / Q000378:metabolism / Q000502:physiology*; D002957:Citrus; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005232:Fatty Acids, Volatile / Q000032:analysis; D005260:Female; D006863:Hydrogen-Ion Concentration; D007476:Ionophores / Q000008:administration & dosage / Q000494:pharmacology*; D007774:Lactation / Q000097:blood / Q000378:metabolism*; D008985:Monensin / Q000008:administration & dosage / Q000494:pharmacology*; D010298:Parity; D011247:Pregnancy; D011897:Random Allocation; D012417:Rumen / Q000378:metabolism*
D001786:Blood Glucose; D002214:Capsules; D005230:Fatty Acids, Nonesterified; D005232:Fatty Acids, Volatile; D007476:Ionophores; D000641:Ammonia; D008985:Monensin; D020155:3-Hydroxybutyric Acid